Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma
Open Access
- 16 April 2010
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 9 (1) , 78
Abstract
Background: The aim of the present study was to analyze the expression of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in nasopharyngeal carcinoma (NPC) and its correlation with clinicopathologic features, including patients' survival time. Methods: Using real-time PCR, we detected the expression of EIF4G1 in normal nasopharyngeal tissues, immortalized nasopharyngeal epithelial cell lines NP69, NPC tissues and cell lines. EIF4G1 protein expression in NPC tissues was examined using immunohistochemistry. Survival analysis was performed using Kaplan-Meier method. The effect of EIF4G1 on cell invasion and tumorigenesis were investigated. Results: The expression levels of EIF4G1 mRNA were significantly greater in NPC tissues and cell lines than those in the normal nasopharyngeal tissues and NP69 cells (P < 0.001). Immunohistochemical analysis revealed that the expression of EIF4G1 protein was higher in NPC tissues than that in the nasopharyngeal tissues (P < 0.001). In addition, the levels of EIF4G1 protein in tumors were positively correlated with tumor T classification (P = 0.039), lymph node involvement (N classification, P = 0.008), and the clinical stages (P = 0.003) of NPC patients. Patients with higher EIF4G 1 expression had shorter overall survival time (P = 0.019). Multivariate analysis showed that EIF4G1 expression was an independent prognostic indicator for the overall survival of NPC patients. Using shRNA to knock down the expression of EIF4G1 not only markedly inhibited cell cycle progression, proliferation, migration, invasion, and colony formation, but also dramatically suppressed in vivo xenograft tumor growth. Conclusion: Our data suggest that EIF4G1 can serve as a biomarker for the prognosis of NPC patients.Keywords
This publication has 31 references indexed in Scilit:
- Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancerMolecular Cancer, 2009
- Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cellsJournal of Experimental & Clinical Cancer Research, 2009
- Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatinJournal of Translational Medicine, 2008
- Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern ChinaJournal of Translational Medicine, 2008
- Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesisHead & Neck, 2008
- The Role of Enhanced Radiosensitivity and Tumor-specific Suicide Gene Vector in Genetherapy of Nasopharyngeal CarcinomaJournal of Radiation Research, 2007
- Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GIRNA, 2005
- RECK is a target of Epstein–Barr virus latent membrane protein 1Oncogene, 2003
- The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits TranslationMolecular and Cellular Biology, 2003
- Integrin (α6β4) regulation of eIF-4E activity and VEGF translationJournal of Cell Biology, 2002